Biote Corp (BTMD)
5.22
+0.06
(+1.06%)
USD |
NASDAQ |
Nov 05, 16:00
5.22
0.00 (0.00%)
After-Hours: 18:56
Biote Enterprise Value: 255.51M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 255.51M |
| November 01, 2024 | 257.53M |
| October 31, 2024 | 253.50M |
| October 30, 2024 | 254.12M |
| October 29, 2024 | 257.53M |
| October 28, 2024 | 257.84M |
| October 25, 2024 | 254.43M |
| October 24, 2024 | 251.02M |
| October 23, 2024 | 256.60M |
| October 22, 2024 | 256.60M |
| October 21, 2024 | 255.67M |
| October 18, 2024 | 260.32M |
| October 17, 2024 | 260.32M |
| October 16, 2024 | 264.35M |
| October 15, 2024 | 261.56M |
| October 14, 2024 | 256.60M |
| October 11, 2024 | 258.46M |
| October 10, 2024 | 255.67M |
| October 09, 2024 | 258.46M |
| October 08, 2024 | 256.91M |
| October 07, 2024 | 254.43M |
| October 04, 2024 | 254.43M |
| October 03, 2024 | 250.40M |
| October 02, 2024 | 257.22M |
| October 01, 2024 | 265.28M |
| Date | Value |
|---|---|
| September 30, 2024 | 268.38M |
| September 27, 2024 | 271.17M |
| September 26, 2024 | 264.35M |
| September 25, 2024 | 265.28M |
| September 24, 2024 | 275.19M |
| September 23, 2024 | 281.70M |
| September 20, 2024 | 282.32M |
| September 19, 2024 | 284.80M |
| September 18, 2024 | 277.67M |
| September 17, 2024 | 282.01M |
| September 16, 2024 | 278.60M |
| September 13, 2024 | 277.05M |
| September 12, 2024 | 273.02M |
| September 11, 2024 | 280.46M |
| September 10, 2024 | 274.88M |
| September 09, 2024 | 286.97M |
| September 06, 2024 | 288.52M |
| September 05, 2024 | 288.83M |
| September 04, 2024 | 284.49M |
| September 03, 2024 | 281.08M |
| August 30, 2024 | 290.07M |
| August 29, 2024 | 289.14M |
| August 28, 2024 | 284.49M |
| August 27, 2024 | 282.63M |
| August 26, 2024 | 285.42M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.78M
Minimum
Aug 22 2022
354.54M
Maximum
Jul 16 2024
140.83M
Average
149.23M
Median
Enterprise Value Benchmarks
| American Shared Hospital Services | 31.12M |
| Novo Integrated Sciences Inc | 4.018M |
| Astrana Health Inc | 2.392B |
| Cryo-Cell International Inc | 68.02M |
| P3 Health Partners Inc | 316.56M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.322M |
| Revenue (Quarterly) | 49.17M |
| Total Expenses (Quarterly) | 42.94M |
| EPS Diluted (Quarterly) | -0.19 |
| Gross Profit Margin (Quarterly) | 68.91% |
| Profit Margin (Quarterly) | -12.86% |
| Earnings Yield | 3.26% |
| Operating Earnings Yield | 17.18% |
| Normalized Earnings Yield | 3.544 |